BRCA1 and lobular breast carcinoma in situ: We did not have data on BRCA1/2 mutations to check if there is any difference in the distribution of these deleterious mutations (and possibly difference in risk of invasive breast cancer) between women with family history of invasive breast cancer and those with family history of breast carcinoma in situ.